Most DCIS breast cancers retained expression of IRF1 in tumor tissue with 23 out of 24 staining positive, whereas IRF5 expression was significantly reduced with only 9 out of 24 staining positive (Figures 1C and 2A). This evidence concerns the gene IRF1 and ductal breast carcinoma in situ.